Other

Weighted-average dividend yield

West Pharmaceutical Services Weighted-average dividend yield remained flat by 0.0% to 0.4% in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from 0.4% to 0.4%. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement
SectionOther
CategoryOther
SignalHigher is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026Apr 23, 2026

How to read this metric

Higher dividend yields generally decrease the fair value of stock options, lowering compensation expense.

Detailed definition

The estimated annual dividend yield used in valuation models to determine the fair value of employee stock options. This...

Peer comparison

Standard disclosure in the footnotes of financial statements for all public companies.

Metric ID: other_share_based_compensation_arrangement_by_share_base_c66307

Historical Data

5 periods
 Q1 '22Q1 '23Q1 '24Q1 '25Q1 '26
Value0.2%0.3%0.3%0.4%0.4%
QoQ Change+50.0%+0.0%+33.3%+0.0%
YoY Change+50.0%+0.0%+33.3%+0.0%
Range0.2%0.4%
CAGR+100.0%
Avg YoY Growth+20.8%
Median YoY Growth+16.7%
Current Streak4+ quarters growth

Weighted-average dividend yield at Other Companies

Frequently Asked Questions

What is West Pharmaceutical Services's weighted-average dividend yield?
West Pharmaceutical Services (WST) reported weighted-average dividend yield of 0.4% in Q1 2026.
How has West Pharmaceutical Services's weighted-average dividend yield changed year-over-year?
West Pharmaceutical Services's weighted-average dividend yield decreased by 0.0% year-over-year, from 0.4% to 0.4%.
What does weighted-average dividend yield mean?
The expected annual dividend rate used to calculate the fair value of employee stock options.